295 related articles for article (PubMed ID: 15090792)
1. Differences in HIV-2 plasma viral load and immune activation in HIV-1 and HIV-2 dually infected persons and those infected with HIV-2 only in Abidjan, Côte D'Ivoire.
Koblavi-Dème S; Kestens L; Hanson D; Otten RA; Borget MY; Bilé C; Wiktor SZ; Roels TH; Chorba T; Nkengasong JN
AIDS; 2004 Feb; 18(3):413-9. PubMed ID: 15090792
[TBL] [Abstract][Full Text] [Related]
2. Dual infection with human immunodeficiency virus type 1 and type 2: impact on HIV type 1 viral load and immune activation markers in HIV-seropositive female sex workers in Abidjan, Ivory Coast.
Nkengasong JN; Kestens L; Ghys PD; Koblavi-Dème S; Otten RA; Bilé C; Maurice C; Kalou M; Laga M; Wiktor SZ; Greenberg AE
AIDS Res Hum Retroviruses; 2000 Sep; 16(14):1371-8. PubMed ID: 11018856
[TBL] [Abstract][Full Text] [Related]
3. Positive association between beta-chemokine-producing T cells and HIV type 1 viral load in HIV-infected subjects in Abidjan, Côte d'Ivoire.
Jennes W; Sawadogo S; Koblavi-Dème S; Vuylsteke B; Maurice C; Roels TH; Chorba T; Nkengasong JN; Kestens L
AIDS Res Hum Retroviruses; 2002 Feb; 18(3):171-7. PubMed ID: 11839151
[TBL] [Abstract][Full Text] [Related]
4. Impact on the immune system of undetectable plasma HIV-1 RNA for more than 2 years.
Arnó A; Ruiz L; Juan M; Zayat MK; Puig T; Balagué M; Romeu J; Pujol R; O'Brien WA; Clotet B
AIDS; 1998 May; 12(7):697-704. PubMed ID: 9619800
[TBL] [Abstract][Full Text] [Related]
5. Correlation of CD8 lymphocyte activation with cellular viremia and plasma HIV RNA levels in asymptomatic patients infected by human immunodeficiency virus type 1.
Bouscarat F; Levacher-Clergeot M; Dazza MC; Strauss KW; Girard PM; Ruggeri C; Sinet M
AIDS Res Hum Retroviruses; 1996 Jan; 12(1):17-24. PubMed ID: 8825614
[TBL] [Abstract][Full Text] [Related]
6. Residual viraemia in HIV-1-infected patients with plasma viral load Ostrowski SR; Katzenstein TL; Pedersen BK; Gerstoft J; Ullum H
Scand J Immunol; 2008 Dec; 68(6):652-60. PubMed ID: 19055701
[TBL] [Abstract][Full Text] [Related]
7. T-cell and B-cell perturbations are similar in ART-naive HIV-1 and HIV-1/2 dually infected patients.
Hønge BL; Petersen MS; Jespersen S; Medina C; Té DDS; Kjerulff B; Jensen MM; Steiniche D; Esbjörnsson J; Laursen AL; Wejse C; Krarup H; Møller BK; Erikstrup C;
AIDS; 2019 Jun; 33(7):1143-1153. PubMed ID: 30845069
[TBL] [Abstract][Full Text] [Related]
8. Plasma viral load, CD4 cell percentage, HLA and survival of HIV-1, HIV-2, and dually infected Gambian patients.
Alabi AS; Jaffar S; Ariyoshi K; Blanchard T; Schim van der Loeff M; Awasana AA; Corrah T; Sabally S; Sarge-Njie R; Cham-Jallow F; Jaye A; Berry N; Whittle H
AIDS; 2003 Jul; 17(10):1513-20. PubMed ID: 12824789
[TBL] [Abstract][Full Text] [Related]
9. Association of immune complexes and plasma viral load with CD4+ cell depletion, CD8+ DR+ and CD16+ cell counts in HIV+ hemophilia patients. Implications for the immunopathogenesis of HIV-induced CD4+ lymphocyte depletion.
Daniel V; Süsal C; Weimer R; Zimmermann R; Huth-Kühne A; Opelz G
Immunol Lett; 2001 Mar; 76(2):69-78. PubMed ID: 11274723
[TBL] [Abstract][Full Text] [Related]
10. Viral load in asymptomatic patients with CD4+ lymphocyte counts above 500 x 10(6)/l.
García F; Vidal C; Gatell JM; Miró JM; Soriano A; Pumarola T
AIDS; 1997 Jan; 11(1):53-7. PubMed ID: 9110075
[TBL] [Abstract][Full Text] [Related]
11. Activation of CD8 T cells normalizes and correlates with the level of infectious provirus in tonsils during highly active antiretroviral therapy in early HIV-1 infection.
Dyrhol-Riise AM; Voltersvik P; Olofsson J; Asjö B
AIDS; 1999 Dec; 13(17):2365-76. PubMed ID: 10597778
[TBL] [Abstract][Full Text] [Related]
12. Relation between HIV-2 proviral load and CD4+ lymphocyte count differs in monotypic and dual HIV infections.
Sarr AD; Popper S; Thior I; Hamel DJ; Sankalé JL; Siby T; Marlink R; Essex M; Mboup S; Kanki P
J Hum Virol; 1999; 2(1):45-51. PubMed ID: 10200599
[TBL] [Abstract][Full Text] [Related]
13. Changes in HIV RNA viral load, CD4+ T-cell counts, and levels of immune activation markers associated with anti-tuberculosis therapy and cotrimoxazole prophylaxis among HIV-infected tuberculosis patients in Abidjan, Cote d'Ivoire.
Kalou M; Sassan-Morokro M; Abouya L; Bile C; Maurice C; Maran M; Tossou O; Roels T; Greenberg AE; Wiktor SZ; Nkengasong JN
J Med Virol; 2005 Feb; 75(2):202-8. PubMed ID: 15602734
[TBL] [Abstract][Full Text] [Related]
14. Increased soluble Fas in HIV-infected hemophilia patients with CD4+ and CD8+ cell count increases and viral load and immune complex decreases.
Daniel V; Süsal C; Weimer R; Zimmermann R; Huth-Kühne A; Opelz G
AIDS Res Hum Retroviruses; 2001 Mar; 17(4):329-35. PubMed ID: 11242519
[TBL] [Abstract][Full Text] [Related]
15. Changes in levels of immune activation and reconstitution markers among HIV-1-infected Africans receiving antiretroviral therapy.
Koblavi-Dème S; Maran M; Kabran N; Borget MY; Kalou M; Kestens L; Maurice C; Sassan-Morokro M; Ekpini ER; Roels TH; Chorba T; Nkengasong JN
AIDS; 2003 Jul; 17 Suppl 3():S17-22. PubMed ID: 14565605
[TBL] [Abstract][Full Text] [Related]
16. A randomized study comparing triple versus double antiretroviral therapy or no treatment in HIV-1-infected patients in very early stage disease: the Spanish Earth-1 study.
García F; Romeu J; Grau I; Sambeat MA; Dalmau D; Knobel H; Gomez-Sirvent JL; Arrizabalaga J; Cruceta A; Clotet BG; Podzamczer D; Pumarola T; Gallart T; O'Brien WA; Miró JM; Gatell JM
AIDS; 1999 Dec; 13(17):2377-88. PubMed ID: 10597779
[TBL] [Abstract][Full Text] [Related]
17. Disease Progression in HIV-1-Infected Viremic Controllers.
Groves KC; Bibby DF; Clark DA; Isaksen A; Deayton JR; Anderson J; Orkin C; Stagg AJ; McKnight A
J Acquir Immune Defic Syndr; 2012 Dec; 61(4):407-16. PubMed ID: 22902723
[TBL] [Abstract][Full Text] [Related]
18. Virologic and immunologic responses to antiretroviral therapy among HIV-1 and HIV-2 dually infected patients: case reports from Abidjan, Côte d'Ivoire.
Borget MY; Diallo K; Adje-Toure C; Chorba T; Nkengasong JN
J Clin Virol; 2009 May; 45(1):72-5. PubMed ID: 19375979
[TBL] [Abstract][Full Text] [Related]
19. Assessment of CD8 T cell immune activation markers to monitor response to antiretroviral therapy among HIV-1 infected patients in Côte d'Ivoire.
Ondoa P; Koblavi-Dème S; Borget MY; Nolan ML; Nkengasong JN; Kestens L
Clin Exp Immunol; 2005 Apr; 140(1):138-48. PubMed ID: 15762885
[TBL] [Abstract][Full Text] [Related]
20. Changes in blood CD8+ lymphocyte activation status and plasma HIV RNA levels during antiretroviral therapy.
Bouscarat F; Levacher M; Landman R; Muffat-Joly M; Girard PM; Saimot AG; Brun-Vézinet F; Sinet M
AIDS; 1998 Jul; 12(11):1267-73. PubMed ID: 9708405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
